Literature DB >> 10227010

A longitudinal study of the effect of vitamin K2 on bone mineral density in postmenopausal women a comparative study with vitamin D3 and estrogen-progestin therapy.

I Iwamoto1, S Kosha, S Noguchi, M Murakami, T Fujino, T Douchi, Y Nagata.   

Abstract

OBJECTIVES: To investigate the effect of vitamin K2 treatment for a year on spinal bone mineral density (BMD) in postmenopausal women, comparing with vitamin D3 hormone replacement therapy and to determine the factors which affect the efficacy of vitamin K2 therapy. SUBJECTS AND METHODS: Seventy-two postmenopausal women were randomized into four groups and treated with respective agents. Before the therapy, 6 and 12 months after the treatment, their lumbar spine BMD were measured by dual energy X-ray absorptiometry. The rates of change in BMD (delta BMD) were calculated. Correlations of BMD with age, year since menopause and the initial BMD were determined.
RESULTS: Vitamin K2 suppressed the decrease in spinal BMD as compared with no treatment group. BMD in women treated with vitamin K2 was inversely correlated with their age (r = -0.54; P < 0.05).
CONCLUSIONS: Vitamin K2 therapy may be a useful method for preventing postmenopausal spinal bone mineral loss. In addition, the therapy should be started early in postmenopausal period.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10227010     DOI: 10.1016/s0378-5122(98)00114-5

Source DB:  PubMed          Journal:  Maturitas        ISSN: 0378-5122            Impact factor:   4.342


  18 in total

1.  Taking our vitamins.

Authors:  Ruth Wilson
Journal:  CMAJ       Date:  2004-04-13       Impact factor: 8.262

2.  Effect of vitamin K on bone mineral density: a meta-analysis of randomized controlled trials.

Authors:  Yanfu Fang; Chuanlai Hu; Xingyong Tao; Yuhui Wan; Fangbiao Tao
Journal:  J Bone Miner Metab       Date:  2011-06-15       Impact factor: 2.626

3.  Effects of combined human parathyroid hormone (1-34) and menaquinone-4 treatment on the interface of hydroxyapatite-coated titanium implants in the femur of osteoporotic rats.

Authors:  Hang Li; Qiang Zhou; Bing-Li Bai; She-Ji Weng; Zong-Yi Wu; Zhong-Jie Xie; Zhen-Hua Feng; Liang Cheng; Viraj Boodhun; Lei Yang
Journal:  J Bone Miner Metab       Date:  2017-12-26       Impact factor: 2.626

4.  Serum level of under-carboxylated osteocalcin and bone mineral density in early menopausal Norwegian women.

Authors:  Nina Emaus; Nguyen D Nguyen; Bjørg Almaas; Gro K Berntsen; Jacqueline R Center; Monika Christensen; Clara G Gjesdal; Anne S Grimsgaard; Tuan V Nguyen; Laila Salomonsen; John A Eisman; Vinjar M Fønnebø
Journal:  Eur J Nutr       Date:  2011-11-30       Impact factor: 5.614

Review 5.  2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada.

Authors:  Jacques P Brown; Robert G Josse
Journal:  CMAJ       Date:  2002-11-12       Impact factor: 8.262

Review 6.  Vitamin K and hepatocellular carcinoma: The basic and clinic.

Authors:  Xia Jinghe; Toshihiko Mizuta; Iwata Ozaki
Journal:  World J Clin Cases       Date:  2015-09-16       Impact factor: 1.337

7.  Vitamin K induces osteoblast differentiation through pregnane X receptor-mediated transcriptional control of the Msx2 gene.

Authors:  Mamoru Igarashi; Yoshiko Yogiashi; Masatomo Mihara; Ichiro Takada; Hirochika Kitagawa; Shigeaki Kato
Journal:  Mol Cell Biol       Date:  2007-09-17       Impact factor: 4.272

8.  Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial.

Authors:  N Emaus; C G Gjesdal; B Almås; M Christensen; A S Grimsgaard; G K R Berntsen; L Salomonsen; V Fønnebø
Journal:  Osteoporos Int       Date:  2009-11-25       Impact factor: 4.507

9.  Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.

Authors:  Noriko Koitaya; Mariko Sekiguchi; Yuko Tousen; Yoriko Nishide; Akemi Morita; Jun Yamauchi; Yuko Gando; Motohiko Miyachi; Mami Aoki; Miho Komatsu; Fumiko Watanabe; Koji Morishita; Yoshiko Ishimi
Journal:  J Bone Miner Metab       Date:  2013-05-24       Impact factor: 2.626

10.  Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover, density, or geometry in healthy postmenopausal North American women.

Authors:  Neil Binkley; Judith Harke; Diane Krueger; Jean Engelke; Nellie Vallarta-Ast; Dessa Gemar; Mary Checovich; Richard Chappell; John Suttie
Journal:  J Bone Miner Res       Date:  2009-06       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.